These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 10827981)

  • 1. Asymmetrical ion-channel model inferred from two-dimensional crystallization of a peptide antibiotic.
    Ionov R; El-Abed A; Angelova A; Goldmann M; Peretti P
    Biophys J; 2000 Jun; 78(6):3026-35. PubMed ID: 10827981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of the peptide antibiotic alamethicin with bilayer- and non-bilayer-forming lipids: influence of increasing alamethicin concentration on the lipids supramolecular structures.
    Angelova A; Ionov R; Koch MH; Rapp G
    Arch Biochem Biophys; 2000 Jun; 378(1):93-106. PubMed ID: 10871049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggregation of a peptide antibiotic alamethicin at the air-water interface and its influence on the viscoelasticity of phospholipid monolayers.
    Krishnaswamy R; Rathee V; Sood AK
    Langmuir; 2008 Oct; 24(20):11770-7. PubMed ID: 18823083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mechanism of channel formation by alamethicin as viewed by molecular dynamics simulations.
    Sansom MS; Tieleman DP; Berendsen HJ
    Novartis Found Symp; 1999; 225():128-41; discussion 141-5. PubMed ID: 10472052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two classes of alamethicin transmembrane channels: molecular models from single-channel properties.
    Mak DO; Webb WW
    Biophys J; 1995 Dec; 69(6):2323-36. PubMed ID: 8599639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extramembrane control of ion channel peptide assemblies, using alamethicin as an example.
    Futaki S; Noshiro D; Kiwada T; Asami K
    Acc Chem Res; 2013 Dec; 46(12):2924-33. PubMed ID: 23680081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuum solvent model calculations of alamethicin-membrane interactions: thermodynamic aspects.
    Kessel A; Cafiso DS; Ben-Tal N
    Biophys J; 2000 Feb; 78(2):571-83. PubMed ID: 10653772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alamethicin and related peptaibols--model ion channels.
    Sansom MS
    Eur Biophys J; 1993; 22(2):105-24. PubMed ID: 7689461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface binding of alamethicin stabilizes its helical structure: molecular dynamics simulations.
    Tieleman DP; Berendsen HJ; Sansom MS
    Biophys J; 1999 Jun; 76(6):3186-91. PubMed ID: 10354443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microscopic visualization of alamethicin incorporation into model membrane monolayers.
    Volinsky R; Kolusheva S; Berman A; Jelinek R
    Langmuir; 2004 Dec; 20(25):11084-91. PubMed ID: 15568861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and orientation of antibiotic peptide alamethicin in phospholipid bilayers as revealed by chemical shift oscillation analysis of solid state nuclear magnetic resonance and molecular dynamics simulation.
    Nagao T; Mishima D; Javkhlantugs N; Wang J; Ishioka D; Yokota K; Norisada K; Kawamura I; Ueda K; Naito A
    Biochim Biophys Acta; 2015 Nov; 1848(11 Pt A):2789-98. PubMed ID: 26248014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational and interfacial analyses of K3A18K3 and alamethicin in model membranes.
    Kouzayha A; Nasir MN; Buchet R; Wattraint O; Sarazin C; Besson F
    J Phys Chem B; 2009 May; 113(19):7012-9. PubMed ID: 19419221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclodextrin-scaffolded alamethicin with remarkably efficient membrane permeabilizing properties and membrane current conductance.
    Hjørringgaard CU; Vad BS; Matchkov VV; Nielsen SB; Vosegaard T; Nielsen NC; Otzen DE; Skrydstrup T
    J Phys Chem B; 2012 Jul; 116(26):7652-9. PubMed ID: 22676384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simulation studies of alamethicin-bilayer interactions.
    Biggin PC; Breed J; Son HS; Sansom MS
    Biophys J; 1997 Feb; 72(2 Pt 1):627-36. PubMed ID: 9017192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alamethicin pyromellitate: an ion-activated channel-forming peptide.
    Woolley GA; Epand RM; Kerr ID; Sansom MS; Wallace BA
    Biochemistry; 1994 Jun; 33(22):6850-8. PubMed ID: 7515685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helical kink and channel behaviour: a comparative study with the peptaibols alamethicin, trichotoxin and antiamoebin.
    Duclohier H
    Eur Biophys J; 2004 May; 33(3):169-74. PubMed ID: 15014907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alamethicin helices in a bilayer and in solution: molecular dynamics simulations.
    Tieleman DP; Sansom MS; Berendsen HJ
    Biophys J; 1999 Jan; 76(1 Pt 1):40-9. PubMed ID: 9876121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational changes in alamethicin associated with substitution of its alpha-methylalanines with leucines: a FTIR spectroscopic analysis and correlation with channel kinetics.
    Haris PI; Molle G; Duclohier H
    Biophys J; 2004 Jan; 86(1 Pt 1):248-53. PubMed ID: 14695266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ion-channel activity of longibrachins LGA I and LGB II: effects of pro-2/Ala and gln-18/Glu substitutions on the alamethicin voltage-gated membrane channels.
    Cosette P; Rebuffat S; Bodo B; Molle G
    Biochim Biophys Acta; 1999 Nov; 1461(1):113-22. PubMed ID: 10556493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Energetics of pore formation induced by membrane active peptides.
    Lee MT; Chen FY; Huang HW
    Biochemistry; 2004 Mar; 43(12):3590-9. PubMed ID: 15035629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.